Total Payments
$4,325
2024 Payments
$544.16
Companies
21
Transactions
271
Medicare Patients
4,621
Medicare Billing
$337,792
Payment Breakdown by Category
Food & Beverage$4,308 (99.6%)
Education$16.54 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,308 | 267 | 99.6% |
| Education | $16.54 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,384 | 72 | $0 (2024) |
| Lilly USA, LLC | $749.52 | 58 | $0 (2024) |
| Novo Nordisk Inc | $516.95 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $378.71 | 27 | $0 (2019) |
| PFIZER INC. | $252.09 | 16 | $0 (2021) |
| ABBVIE INC. | $244.24 | 9 | $0 (2024) |
| Organon LLC | $113.85 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $109.77 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.40 | 6 | $0 (2024) |
| Amgen Inc. | $79.67 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.16 | 22 | AstraZeneca Pharmaceuticals LP ($186.96) |
| 2023 | $95.26 | 5 | AstraZeneca Pharmaceuticals LP ($59.63) |
| 2022 | $441.49 | 15 | AstraZeneca Pharmaceuticals LP ($226.93) |
| 2021 | $472.59 | 26 | AstraZeneca Pharmaceuticals LP ($126.81) |
| 2020 | $403.95 | 27 | AstraZeneca Pharmaceuticals LP ($163.39) |
| 2019 | $229.67 | 15 | AstraZeneca Pharmaceuticals LP ($68.38) |
| 2018 | $865.05 | 65 | Novo Nordisk Inc ($244.96) |
| 2017 | $1,273 | 96 | AstraZeneca Pharmaceuticals LP ($348.93) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $90.57 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: DIABETES | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,049 | 1,497 | $193,917 | $85,567 |
| 2022 | 24 | 1,468 | 2,127 | $232,626 | $102,684 |
| 2021 | 26 | 1,283 | 1,898 | $193,824 | $91,909 |
| 2020 | 16 | 821 | 1,307 | $136,514 | $57,632 |
Total Patients
4,621
Total Services
6,829
Medicare Billing
$337,792
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 407 | $69,190 | $23,500 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $45,384 | $23,353 | 51.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $16,422 | $9,604 | 58.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 102 | 102 | $12,138 | $7,337 | 60.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 93 | $22,320 | $7,298 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 112 | 112 | $4,368 | $3,377 | 77.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 202 | 348 | $3,440 | $2,887 | 83.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 71 | $7,455 | $2,762 | 37.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $5,652 | $2,644 | 46.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $1,326 | $1,025 | 77.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 18 | $2,070 | $623.16 | 30.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 13 | $1,890 | $511.17 | 27.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 24 | $1,248 | $381.15 | 30.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $864.00 | $180.32 | 20.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 25 | $150.00 | $85.25 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 176 | 439 | $74,630 | $25,997 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 173 | 173 | $39,572 | $22,468 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 135 | $32,400 | $12,036 | 37.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 32 | 32 | $15,397 | $8,880 | 57.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 82 | 82 | $9,758 | $5,620 | 57.6% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 96 | 96 | $7,008 | $3,648 | 52.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 116 | 116 | $4,524 | $3,403 | 75.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 58 | 71 | $8,165 | $2,478 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 65 | $6,825 | $2,374 | 34.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $3,269 | $1,857 | 56.8% |
About Dr. Raymond Bishop, MD
Dr. Raymond Bishop, MD is a Family Medicine healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609865591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raymond Bishop, MD has received a total of $4,325 in payments from pharmaceutical and medical device companies, with $544.16 received in 2024. These payments were reported across 271 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,308).
As a Medicare-enrolled provider, Bishop has provided services to 4,621 Medicare beneficiaries, totaling 6,829 services with total Medicare billing of $337,792. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pikeville, KY
- Active Since 10/14/2005
- Last Updated 05/12/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609865591
Products in Payments
- FARXIGA (Drug) $773.68
- TRULICITY (Drug) $519.40
- Victoza (Drug) $272.13
- TOUJEO (Drug) $219.30
- VRAYLAR (Drug) $213.06
- SYMBICORT (Drug) $197.03
- BREZTRI (Drug) $163.32
- SOLIQUA (Drug) $159.41
- AIRSUPRA (Drug) $135.75
- MOUNJARO (Drug) $122.40
- Ozempic (Drug) $122.26
- JARDIANCE (Drug) $118.48
- CHANTIX (Drug) $104.43
- NEXPLANON (Drug) $79.19
- XARELTO (Drug) $71.23
- BEVESPI AEROSPHERE (Drug) $70.51
- ASMANEX (Drug) $58.03
- Prolia (Biological) $50.53
- Phasix (Device) $49.00
- PREMARIN (Drug) $48.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pikeville
Dr. Suzanne Ford, Do, DO
Family Medicine — Payments: $19,832
Family Medicine $19,832
Samuel King, M. D, M. D
Family Medicine — Payments: $11,120
Family Medicine $11,120
Dr. Jeremy Parsons, M.d, M.D
Family Medicine — Payments: $9,605
Family Medicine $9,605
Dr. James Hager, D.o, D.O
Family Medicine — Payments: $5,599
Family Medicine $5,599
Janey Watts, Do, DO
Family Medicine — Payments: $4,447
Family Medicine $4,447
Alexis Ravi, D.o, D.O
Family Medicine — Payments: $3,952
Family Medicine $3,952